International repercussions of the FIFA corruption scandal. China outlines a new military strategy in the South China Sea. And the Iraqi military launches a new offensive near Ramadi. A panel of journalists joins Diane for analysis of the week's top international news stories.
The European Union yesterday reached a preliminary agreement to ban imports of Iranian oil. On Saturday, President Obama signed a bill imposing new sanctions on Iran’s central bank. The intention is to pressure Iran to curtail its nuclear program. But Tehran has responded with threats to close the Strait of Hormuz and attack U.S. naval vessels in the Gulf. The country also launched an anti-American campaign in Afghanistan. Diane and her guests discuss what is behind the recent escalation of threats and sanctions, the political and economic implications and whether military conflict is becoming more of a concern.
- Michael Rubin resident scholar, American Enterprise Institute, senior lecturer, Naval Postgraduate School, and author of the forthcoming book, "Dancing with the Devil" (Encounter, 2013.
- Ellen Laipson president and CEO of the Stimson Center, member of the U.S. State Department's Foreign Affairs Policy Board.
- Reza Marashi research director, National Iranian American Council, former Iran desk officer, U.S. State Department.
Most Recent Shows
The Justice Department charges FIFA soccer officials with corruption. More contenders enter the already-crowded 2016 presidential race. And former House Speaker Dennis Hastert is indicted for violating banking laws and lying to the FBI. A panel of journalists joins Diane for analysis of the week's top national news stories.
Research psychologist Penelope Leach is known for her best-selling guides on child development, including "Babyhood" and "Your Baby and Child." In her latest book, she explains what the latest research says about helping children cope with separation and divorce.
More than half a million Americans have annual prescription drug bills of at least $50,000. Please join us to discuss what's behind soaring drug costs and the push for new pricing models.